CORONA Remedies Limited has informed the Exchange about Schedule of meet
CORONA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CORONA Remedies has informed the exchanges that it will hold its Q2 FY26 earnings conference call on Monday, January 5, 2026 at 12:00 PM IST. The call, organized by JM Financial Institutional Securities, will discuss the company's financial results for the second quarter and half year ended September 30, 2025. The company's senior leadership, including Managing Director & CEO Nirav Mehta, Joint Managing Director Ankur Mehta, and CFO Bhavin Bhagat, will participate alongside the senior management team. Dial-in details have been provided for both domestic and international investors and analysts.
This is a routine regulatory disclosure that does not contain any new financial figures. However, it signals that Q2 FY26 results will be shared soon and gives investors and analysts an opportunity to hear directly from the company's top leadership about performance and outlook.